Skip to content
Kalpvruksh Markets
Offline Log in

SUPRIYANSEOffline

SUPRIYA LIFESCIENCE · INE07RO01027 · Small Cap · #738
869.60+9.70 (+1.13%)last close · 05 Nov 2026
Prev close
859.90
Open
—
High
—
Low
—
Volume
—
Mkt cap (6-mo avg)
₹5,822 cr
52-week range · to 05 Nov 2026553.351,052.5

Loading minute bars…

NSE 1-minute bars from our CandleApi gateway (history from 21 Jul 2026); longer timeframes are built from them. Prices not adjusted for corporate actions.

SUPRIYA is 17% below its 52-week high, above its 200-day average — a Small Cap company, #738 by market cap. Now under exchange surveillance.NSE prices to 05 Nov 2026 · a description of the data, not advice

Overview

What the data says, line by line

A description, never a buy or sell word · tap a line for its detail

  • above its 20 / 200-day averages · below its 50-day average · 17% below its 52-week high
  • −2.7% vs Nifty 500
  • traded value 0.6× usual · delivery 49% vs 43% usual
  • FPI +0.3 pp · DII +0.2 pp · MF schemes in Sept 2026: 6 bought, 2 cut · no promoter pledge · quarter ended 2026-09-30
  • ASM short-term 1

How big is it?

six-month average market cap

Market capitalisation
₹5,822 cr
Rank
#738
Cap band
Small Cap
Nearest cut-off — Mid / Small
−82.97% from ₹34,190 cr
Clear of the cut-off

Our own six-month average, computed the way AMFI computes it; the published classification is on the market cap page.

Did buyers take delivery?

latest session · 2026-11-05

vs its own normal
1.1×
median 68,789
Delivered
74,237
Of volume
48%

Trading restrictions

Under surveillance
ASM short-term 1 (2026-11-13)

Price & trend

Returns

to 05 Nov 2026

PeriodStockvs Nifty 500vs its industry
1 week+0.0%−5.5 pts—
1 month−5.0%−9.2 pts—
3 months−4.8%−2.7 pts—
6 months+23.5%+23.0 pts—
1 year+15.7%+18.8 pts—

Points = the stock’s return minus the benchmark’s. Prices adjusted for splits and bonuses.

Averages & movement

vs 20-day average
+1.6%
above
vs 50-day average
−1.0%
below
vs 200-day average
+10.4%
above
ATR (14)
3.6%
typical daily range
Volatility
34%
1 month, annualised
Beta
0.93
vs Nifty 500, 1 year
Traded value
0.6×
vs usual
Delivery
49%
usual 43%
From the 52-week high
−17.4%
place in range 63% (0 = at the low)

Ownership

Who owns the company

% of all shares, by quarter

GroupDec 25Mar 26Jun 26Sep 26
Promoters68.3%68.3%68.3%68.3%
FPI5.2%5.2%6.2% +1.06.5% +0.3
Mutual funds0.7%1.3% +0.71.3%1.3%
Other DII4.3%4.4%4.0% −0.44.2% +0.2
Individuals16.7%16.2% −0.416.0% −0.215.4% −0.6
Others4.9%4.6% −0.24.2% −0.44.4% +0.1

From the company’s quarterly shareholding pattern. Changes in percentage points against the quarter before. No quarters are on record between Sep 2022 and Jun 2025.

Promoter pledge

Sep 26

Of promoters’ holding
none
Of all shares
none
Jun 25 noneSep 25 noneDec 25 noneMar 26 noneJun 26 noneSep 26 none

Holders

Sep 26

All shareholders
78,561
Individuals
74,683

Indian passive funds’ stake

2026-06-30

Of free float
0.29%
Of all shares
0.09%
Schemes
11
Days to unwind
0.3
at 100% of volume

72,755 shares held by Indian passive mutual-fund schemes. A floor, not the total — foreign ETFs, insurance and EPFO are not counted.

Which funds bought and sold

mutual funds · quarter ended 2026-06-30

Funds holding
18
11 index · 7 active
Bought more
7
Sold some
4
FundSharesChangeDid
Abakkus Flexi Cap Fund-Reg(G)Active+12,711+2.4%bought
ITI Large & Mid Cap Fund-Reg(G)Active−54,447−29.8%sold
WOC Pharma and Healthcare Fund-Reg(G)Active−6,666−10.5%sold
Motilal Oswal Nifty Microcap 250 Index Fund-Reg(G)Index−6,194−8.1%sold

Ranked by how much each fund changed its own position, not by size of trade. Every fund here still holds the company — one that sold out entirely leaves no record to find.

Mutual-fund schemes, month by month

fund houses’ own monthly portfolios

MonthSchemesBought newAddedCutSold outShares heldValue
Sep 26141520+1.2%₹75 cr
Aug 26131621−1.3%₹63 cr
Jul 26131231−0.3%₹69 cr
Jun 26133330+1.8%₹81 cr
May 26100230−0.3%₹76 cr
Apr 26100420+1.4%₹54 cr

Each month against the one before, counting only the fund houses that reported both (45 houses in Sep 26); a split or bonus is divided out first. “Partial” = fewer than five houses reported yet.

Fund ownership is a quarterly disclosure and counts Indian passive schemes only.

Results

Results

Events & filings

Insider trades

SEBI PIT disclosures filed with NSE

Promoter group
No market buy or sell
Directors & KMP
No market buy or sell
Others
No market buy or sell
Latest 2 of 2 disclosures
0 selected
26 Feb 2024Saloni Satish WaghPromoter GroupSell73,125₹00.13%Gift
26 Feb 2024Shivani Satish WaghPromoter GroupBuy73,125₹00.13%Gift

Sums count buys and sells of equity (market and off-market); pledges are listed but not summed. From NSE’s filings: the archive to 2 May 2026, its XBRL filings since (NSE circular NSE/CML/2026/12). A filing describes what was done, not why.

Disclosures & deals

last six months · NSE filings

  • Board outcome
    Supriya Lifescience Limited has submitted to the Exchange, the financial results for the period ended March 31, 2026.
    29 May 2026
  • Board outcome
    Outcome of Board Meeting-XBRL SUPRIYA LIFESCIENCE LIMITED has informed the Exchange regarding Outcome of Board Meeting held on 27-May-2026 for Dividend
    29 May 2026

SUPRIYA: only ratings, pledges, insider and takeover disclosures, buybacks, schemes, board outcomes and deals are listed. All deals.

Corporate actions

full published history

0 selected
RecentDividend₹1Final04 Sept 202604 Sept 2026
EarlierDividend₹1Final04 Sept 202505 Sept 2025
EarlierDividend₹0.8Final20 Sept 202421 Sept 2024
EarlierDividend₹0.6Final15 Sept 202316 Sept 2023
EarlierDividend₹0.6Final01 Sept 202203 Sept 2022

5 shown. A falling price on an ex-date is not a loss: a dividend leaves the share as cash and a bonus multiplies the shares held.

Market capitalisation is our own six-month average, computed the way AMFI computes it; the published classification is on the market cap page. Fund ownership is a quarterly disclosure and counts Indian passive schemes only. Nothing here is advice, a recommendation, or a view on the company.